方舟在中国医疗应用的App Store排行榜上名列前茅-动脉网

Fangzhou Tops China's App Store Chart for Healthcare Apps

CISION 等信源发布 2025-07-03 18:43



可切换为仅中文







GUANGZHOU, China

中国广州

，

July 3, 2025

2025年7月3日

/PRNewswire/ -- Fangzhou Inc. ('Fangzhou' or the 'Company') (06086.HK), a leader in Internet healthcare solutions, earned the top spot in the

/PRNewswire/ -- 方舟科技（“方舟”或“公司”）（06086.HK），互联网医疗解决方案的领军企业，荣登榜首。

June 2025

2025年6月

China AppStore Healthcare TOP100 Free APP Rankings with its Fangzhou Online Pharmacy App, according to a report by the leading digital economy media outlet 100EC.cn. The achievement follows a nine-position surge from May's rankings, reflecting increasing user adoption of the Company's AI-enabled healthcare solutions..

中国AppStore医疗保健类TOP100免费应用排名中，方舟在线药房App榜上有名，据领先的数字经济媒体100EC.cn报道。这一成绩较5月的排名提升了九位，反映出用户对公司人工智能医疗解决方案的采用率正在增加。

Third-party analytics show Fangzhou's online pharmacy has maintained its position as

第三方分析显示，方舟在线药店保持了其地位作为

China's

中国的

most active healthcare vertical platform since 2020. The platform's registered user base grew from 42.7 million registered users in 2023 to 49.2 million as of

自2020年以来最活跃的医疗垂直平台。该平台的注册用户从2023年的4270万增长到截至当时的4920万。

December 31, 2024

2024年12月31日

, while monthly active users reached 10.1 million — a 20% year-on-year increase. This growth results from ongoing AI-powered enhancements to Fangzhou's chronic disease management services, which have significantly improved user engagement and retention.

，月活跃用户达到了 1010 万——同比增长了 20%。这一增长得益于方舟持续利用人工智能技术改进其慢性病管理服务，从而显著提高了用户的参与度和留存率。

Dr. Xie Fangmin, founder, chairman, and CEO of Fangzhou, commented, 'Achieving this top ranking affirms our AI-driven approach to Internet healthcare. It also reflects

谢方民博士，方舟的创始人、董事长兼首席执行官评论道：“取得这一最高排名肯定了我们以人工智能驱动的互联网医疗方式。这也反映了

China's

中国的

rapidly growing demand for convenient, reliable digital medical services. We remain committed to technological innovation that addresses evolving healthcare needs of our customers.'

对便捷、可靠的数字医疗服务的需求迅速增长。我们始终致力于技术创新，以满足客户不断变化的医疗需求。

Technology-Driven Solutions

技术驱动的解决方案

The Company's digital supply chain network now connects with over 1,500 suppliers and 900 pharmaceutical companies, including major multinational and domestic leaders. This extensive partnership network enables the Company to offer the widest possible selection of prescription drugs, ensuring comprehensive access for patients nationwide..

公司的数字供应链网络现已连接超过1500家供应商和900家制药公司，其中包括主要的跨国公司和国内领军企业。这一广泛的合作伙伴网络使公司能够提供尽可能多的处方药品种，确保全国各地患者获得全面的药品可及性。

AI-Powered Innovation

人工智能驱动的创新

Looking ahead, Fangzhou will continue to embrace its core philosophy of advancing growth through AI-enabled innovation. By leveraging its advanced technological capabilities, the company aims to meet the rising demand for personalized health services while making significant contributions to the Healthy China 2030 objectives. Fangzhou is focused on integrating advanced AI technologies with healthcare solutions to enhance service quality, increase accessibility, and pioneer new digital health management models that align with national health priorities and the evolving needs of patients..

展望未来，方舟将继续秉持通过人工智能驱动的创新推动发展的核心理念。通过利用其先进的技术能力，公司旨在满足个性化健康服务日益增长的需求，同时为“健康中国2030”目标作出重要贡献。方舟专注于将先进的人工智能技术与医疗保健解决方案相结合，以提高服务质量、增加可及性，并开创符合国家健康优先事项和患者不断变化需求的新型数字健康管理模型。

About Fangzhou Inc.

关于方舟公司

Fangzhou Inc. (06086.HK) is

方舟有限公司（06086.HK）是

China's

中国的

leading online chronic disease management platform, serving 49.2 million registered users and 223,000 physicians (as of

领先的在线慢性病管理平台，服务4920万注册用户和22.3万名医生（截至

December 31, 2024

2024年12月31日

). The Company specializes in delivering tailored medical care and precision medicine solutions. For more information, visit

）。公司专注于提供定制的医疗护理和精准医疗解决方案。欲了解更多信息，请访问

https://investors.jianke.com

About the Ranking

关于排名

Compiled by the E-Commerce Research Center and the Digital Healthcare Unit of 100EC.cn, the monthly AppStore China Free Rankings (Healthcare) TOP100 represents one of

由电子商务研究中心和100EC.cn数字健康单元编制的每月AppStore中国免费排名（医疗保健）TOP100代表了其中之一。

China's

中国的

most authoritative assessments of medical app performance.

最权威的医疗应用程序性能评估。

Media Contact

媒体联系人

For further inquiries or interviews, please reach out to:

如有进一步查询或采访需求，请联系：

Xingwei Zhao

赵兴伟

Associate Director of Public Relations Email:

公共关系副总监电子邮件：

pr@jianke.com

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements

免责声明：本新闻稿包含前瞻性陈述。由于各种因素，实际结果可能与预期有重大差异。读者被提醒不要过分依赖这些陈述。

SOURCE Fangzhou Inc.

来源：方舟公司

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻吗？

FEATURED ON PRNEWSWIRE.COM?

荣登PRNEWSWIRE.COM？

440k+

44万+

Newsrooms &

新闻编辑室 &

Influencers